Matches in Wikidata for { <http://www.wikidata.org/entity/Q43138653> ?p ?o ?g. }
- Q43138653 description "2010 nî lūn-bûn" @default.
- Q43138653 description "2010 മാര്ച്ച് 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q43138653 description "2010年の論文" @default.
- Q43138653 description "2010年学术文章" @default.
- Q43138653 description "2010年学术文章" @default.
- Q43138653 description "2010年学术文章" @default.
- Q43138653 description "2010年学术文章" @default.
- Q43138653 description "2010年学术文章" @default.
- Q43138653 description "2010年学术文章" @default.
- Q43138653 description "2010年學術文章" @default.
- Q43138653 description "2010年學術文章" @default.
- Q43138653 description "2010年學術文章" @default.
- Q43138653 description "2010年學術文章" @default.
- Q43138653 description "2010年學術文章" @default.
- Q43138653 description "2010년 논문" @default.
- Q43138653 description "article científic" @default.
- Q43138653 description "article scientific" @default.
- Q43138653 description "article scientifique" @default.
- Q43138653 description "articol științific" @default.
- Q43138653 description "articolo scientifico" @default.
- Q43138653 description "artigo científico" @default.
- Q43138653 description "artigo científico" @default.
- Q43138653 description "artigo científico" @default.
- Q43138653 description "artikel ilmiah" @default.
- Q43138653 description "artikull shkencor" @default.
- Q43138653 description "artikulong pang-agham" @default.
- Q43138653 description "artykuł naukowy" @default.
- Q43138653 description "artículo científico publicado en 2010" @default.
- Q43138653 description "artículu científicu espublizáu en 2010" @default.
- Q43138653 description "bilimsel makale" @default.
- Q43138653 description "bài báo khoa học" @default.
- Q43138653 description "naučni članak" @default.
- Q43138653 description "scienca artikolo" @default.
- Q43138653 description "scientific article published in March 2010" @default.
- Q43138653 description "scientific article published in March 2010" @default.
- Q43138653 description "scientific article published in March 2010" @default.
- Q43138653 description "teaduslik artikkel" @default.
- Q43138653 description "tieteellinen artikkeli" @default.
- Q43138653 description "tudományos cikk" @default.
- Q43138653 description "vedecký článok" @default.
- Q43138653 description "vetenskaplig artikel" @default.
- Q43138653 description "videnskabelig artikel" @default.
- Q43138653 description "vitenskapelig artikkel" @default.
- Q43138653 description "vitskapeleg artikkel" @default.
- Q43138653 description "vědecký článek" @default.
- Q43138653 description "wetenschappelijk artikel" @default.
- Q43138653 description "wissenschaftlicher Artikel" @default.
- Q43138653 description "επιστημονικό άρθρο" @default.
- Q43138653 description "мақолаи илмӣ" @default.
- Q43138653 description "наукова стаття, опублікована в березні 2010" @default.
- Q43138653 description "научна статия" @default.
- Q43138653 description "научная статья" @default.
- Q43138653 description "научни чланак" @default.
- Q43138653 description "научни чланак" @default.
- Q43138653 description "מאמר מדעי" @default.
- Q43138653 description "مقالة علمية نشرت في مارس 2010" @default.
- Q43138653 description "মার্চ ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43138653 description "บทความทางวิทยาศาสตร์" @default.
- Q43138653 description "სამეცნიერო სტატია" @default.
- Q43138653 name "Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment" @default.
- Q43138653 name "Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment" @default.
- Q43138653 type Item @default.
- Q43138653 label "Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment" @default.
- Q43138653 label "Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment" @default.
- Q43138653 prefLabel "Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment" @default.
- Q43138653 prefLabel "Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment" @default.
- Q43138653 P1433 Q43138653-C57536EC-5651-4667-8DA5-B047825B86DB @default.
- Q43138653 P1476 Q43138653-5D746CAB-44B4-4946-B21C-D104A12B813B @default.
- Q43138653 P2093 Q43138653-0E3A5F80-8D8C-4121-8566-14DEFD1F3A0E @default.
- Q43138653 P2093 Q43138653-7A4466AC-0B00-458B-9D97-46E0F3C61B27 @default.
- Q43138653 P2093 Q43138653-9A4FF4DC-B1A0-4E00-88C2-554D168A9141 @default.
- Q43138653 P2093 Q43138653-9DEBA2F4-FC63-4532-8C4C-6B78A42E6115 @default.
- Q43138653 P2093 Q43138653-A5441C3D-C4E3-45EE-83AE-55EAF07A09E1 @default.
- Q43138653 P2093 Q43138653-F0C5F1FC-C64E-42AF-9F4A-D6BC3809EB26 @default.
- Q43138653 P304 Q43138653-B1B45972-FEF5-4FAA-B45E-0A87C6D5DF46 @default.
- Q43138653 P31 Q43138653-764675B5-B4E8-44EE-9886-39B54EC9BC9A @default.
- Q43138653 P356 Q43138653-A56254D7-303F-4590-A17D-13CB382FFE46 @default.
- Q43138653 P407 Q43138653-AA14EA13-B918-4A88-B626-04A34BF821E1 @default.
- Q43138653 P433 Q43138653-699FB6C0-1C80-432F-B481-DEB3F215AC48 @default.
- Q43138653 P478 Q43138653-E5E56008-FB8C-4E7B-B332-970AD6839DCF @default.
- Q43138653 P50 Q43138653-4F8D5102-5C18-4215-AF44-38E16FC2C088 @default.
- Q43138653 P50 Q43138653-4FE7BEDF-38B8-4DF1-BAC8-91D759365A6B @default.
- Q43138653 P50 Q43138653-5DC58CB7-F1D6-4D30-A3A9-B100BF3B1807 @default.
- Q43138653 P50 Q43138653-8761A871-46DE-4824-9C23-5AF395626E2D @default.
- Q43138653 P50 Q43138653-9E11FD6D-02AD-4DEC-972B-117E918A2D19 @default.
- Q43138653 P50 Q43138653-C948364B-7884-448B-BED7-D1FF6A1D89BA @default.
- Q43138653 P50 Q43138653-E44FCECF-211E-43D8-80ED-A44D9A6A30E7 @default.
- Q43138653 P577 Q43138653-F54FB6BD-047C-42CA-90ED-A1CF85B5E5B0 @default.
- Q43138653 P698 Q43138653-F7FEEBB3-C7D7-40F5-BD71-A14874DD0739 @default.
- Q43138653 P921 Q43138653-1295DBCA-2D8A-430F-AF3E-088BCFADCAA4 @default.
- Q43138653 P921 Q43138653-272265e6-0b4a-4a78-8a1e-0344450f39b0 @default.
- Q43138653 P921 Q43138653-AB0F26B3-C45F-4467-9014-E8B768A3CD3D @default.
- Q43138653 P921 Q43138653-BB7A409A-5F9D-4473-83EE-72192D3D617C @default.
- Q43138653 P921 Q43138653-ffa0fb8e-b74b-4ac2-9d6a-6abffdfa4116 @default.
- Q43138653 P356 J.AHJ.2009.08.026 @default.
- Q43138653 P698 20211294 @default.
- Q43138653 P1433 Q2227156 @default.
- Q43138653 P1476 "Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment" @default.
- Q43138653 P2093 "David Synhorst" @default.
- Q43138653 P2093 "Greg Flaker" @default.